Related Experiment Videos
Pneumococcal antibody responses in elite swimmers
M Gleeson1, D B Pyne, W A McDonald
1Hunter Immunology Unit, Royal Newcastle Hospital, NSW, Australia.
Clinical and Experimental Immunology
|August 1, 1996
Summary
Elite swimmers mounted an antibody response to Pneumovax 23 comparable to sedentary individuals. Despite lower baseline immunoglobulins, swimmers showed enhanced IgG subclass responses post-vaccination, indicating robust immune function during intense training.
Area of Science:
- Immunology
- Sports Medicine
- Vaccinology
Background:
- Elite athletes undergo rigorous training, potentially impacting immune function.
- Pneumococcal vaccination (Pneumovax 23) elicits an antibody response crucial for infection prevention.
- Understanding immune responses in athletes is vital for maintaining health and performance.
Purpose of the Study:
- To evaluate the antibody response to Pneumovax 23 in elite swimmers post-intensive training.
- To compare immune responses between elite swimmers and sedentary controls.
- To investigate correlations between antibody response, performance, infection rates, and psychological variables.
Main Methods:
- Assessed antibody titres to six pneumococcal serotypes in 20 elite swimmers and 19 sedentary controls.
- Measured serum immunoglobulin isotypes and IgG subclasses before and after vaccination.
- Utilized the Profile of Mood States (POMS) questionnaire for psychological assessment.
Main Results:
- No significant differences in pneumococcal antibody responses between swimmers and controls.
- Swimmers had lower prevaccination IgG2 and IgG3 levels but showed greater post-vaccination IgG1, IgG3, and IgG4 subclass responses.
- No correlations found between antibody response and performance, infection rates, or psychological variables.
Conclusions:
- Elite swimmers demonstrate an equivalent antibody response to Pneumovax 23 compared to sedentary individuals.
- Intensive training does not impair the ability to respond to pneumococcal vaccination.
- Swimmers exhibit a heightened polyclonal immunoglobulin response post-vaccination, particularly in specific IgG subclasses.